Also effective April 28, 2023, the Board appointed George S. M. Dyer, MD, to fill the vacancy caused by Mr. Unger’s departure and to serve in the class of directors whose terms expire at the annual stockholder meeting in 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Kevin Unger resigned as Director at ORTHOPEDIATRICS CORP.
Action
resigned
Role
Director
Exact text from the filing
On April 27, 2023, the Board accepted the resignation of Kevin Unger as a member of the Board, which became effective April 28, 2023.
George S. M. Dyer, MD was appointed as Director at ORTHOPEDIATRICS CORP.
Action
appointed
Role
Director
Exact text from the filing
Also effective April 28, 2023, the Board appointed George S. M. Dyer, MD, to fill the vacancy caused by Mr. Unger’s departure and to serve in the class of directors whose terms expire at the annual stockholder meeting in 2023.
ORTHOPEDIATRICS CORP completed an acquisition involving Kevin Unger and DINZE LLC for approximately $15.2 million (closed 2023-05-01).
Action
acquisition
Counterparty
Kevin Unger and DINZE LLC
Consideration
approximately $15.2 million
Closing
2023-05-01
Exact text from the filing
revenue contributions from the platform in 2023. Under the terms of the Purchase Agreement, the Sellers will be paid consideration in the aggregate amount of approximately $15.2 million, payable in the following manner: (i) cash in the aggregate amount of $3.0 million, on the transaction closing date (the “Closing Date”); (ii) 43,751 unregistered shares of the
Material AgreementsSEC 8-K Item 1.01/1.02confidence 0.9
ORTHOPEDIATRICS CORP entered into Membership Interest Purchase Agreement with Kevin Unger and DINZE LLC valued at approximately $15.2 million (effective 2023-05-01).
Action
entry
Agreement
asset purchase
Counterparty
Kevin Unger and DINZE LLC
Value
approximately $15.2 million
Effective
2023-05-01
Exact text from the filing
On May 1, 2023, OrthoPediatrics Corp. (the “Company”) entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Kevin Unger and DINZE LLC, an Ohio limited liability company (collectively, the “Sellers”), and the sole member of DINZE LLC, providing for the purchase by the Company of all of the issued and outstanding membership interest of Medtech Concepts, LLC
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.